Neonatal soft tissue sarcomas

被引:49
作者
Ferrari, Andrea [1 ]
Orbach, Daniel [2 ]
Sultan, Iyad [3 ]
Casanova, Michela [1 ]
Bisogno, Gianni [4 ]
机构
[1] Fdn IRCCS Ist Nazl Tumori, Pediat Oncol Unit, I-20133 Milan, MI, Italy
[2] Inst Curie, Dept Pediat, Paris, France
[3] King Hussein Canc Ctr, Dept Pediat Oncol, Amman, Jordan
[4] Univ Padua, Pediat Hematol & Oncol Div, Padua, Italy
关键词
Infantile fibrosarcoma; Infants; Neonatal; Rhabdomyosarcoma; Soft tissue sarcomas; Vascular tumors; HEPATIC EPITHELIOID HEMANGIOENDOTHELIOMA; CONGENITAL-INFANTILE FIBROSARCOMA; RHABDOID TUMORS; PEDIATRIC-ONCOLOGY; INTERNATIONAL-SOCIETY; MESENCHYMAL TUMOR; 1ST YEAR; RHABDOMYOSARCOMA; AGE; HEMANGIOMAS;
D O I
10.1016/j.siny.2012.05.003
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Soft tissue tumors in very young children pose diagnostic and therapeutic challenges. Vascular tumors are the most prevalent soft tissue neoplasms in the neonatal period. They are generally benign tumors, but may exhibit aggressive behaviour and cause life-threatening complications. Fibroblastic tumors of intermediate prognosis, more prevalent in very young children (especially infantile fibrosarcoma), are locally aggressive. Since metastases are unusual in this group of tumors, complete surgical resection is generally curative. However, these tumors often present a therapeutic challenge because of the location which makes complete surgical resection difficult. Among the malignant soft tissue tumors, rhabdomyosarcoma is most frequent. It is an aggressive high-grade tumor, with local invasiveness and a propensity to metastasize. These tumors respond to chemotherapy and radiotherapy. Neonates with rhabdomyosarcoma seem to have a worse prognosis than in older age groups. This may be a result of inappropriate dosing of chemotherapeutic agents and decreased use of radiation therapy among other factors. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:231 / 238
页数:8
相关论文
共 51 条
[1]  
Alaggio R, 2006, AM J SURG PATHOL, V30, P388
[2]  
Biegel JA, 1999, CANCER RES, V59, P74
[3]   Extra-renal non-cerebral rhabdoid tumours [J].
Bourdeaut, Franck ;
Freneaux, Paul ;
Thuille, Benedicte ;
Bergeron, Christophe ;
Laurence, Valerie ;
Brugieres, Laurence ;
Verite, Cecile ;
Michon, Jean ;
Delattre, Olivier ;
Orbach, Daniel .
PEDIATRIC BLOOD & CANCER, 2008, 51 (03) :363-368
[4]   Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors [J].
Bourgeois, JM ;
Knezevich, SR ;
Mathers, JA ;
Sorensen, PHB .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2000, 24 (07) :937-946
[5]  
Calabrò L, 2007, J EXP CLIN CANC RES, V26, P145
[6]  
COFFIN CM, 1993, PATHOL ANNU, V28, P97
[7]   SO-CALLED CONGENITAL-INFANTILE FIBROSARCOMA - DOES IT EXIST AND WHAT IS IT [J].
COFFIN, CM ;
JASZCZ, W ;
OSHEA, PA ;
DEHNER, LP .
PEDIATRIC PATHOLOGY, 1994, 14 (01) :133-150
[8]   Molecular and cellular biology of rhabdomyosarcoma [J].
De Giovanni, Carla ;
Landuzzi, Lorena ;
Nicoletti, Giordano ;
Lollini, Pier-Luigi ;
Nanni, Patrizia .
FUTURE ONCOLOGY, 2009, 5 (09) :1449-1475
[9]   Treatment of Nonmetastatic Cranial Parameningeal Rhabdomyosarcoma in Children Younger Than 3 Years Old: Results From International Society of Pediatric Oncology Studies MMT 89 and 95 [J].
Defachelles, Anne-Sophie ;
Rey, Annie ;
Oberlin, Odile ;
Spooner, David ;
Stevens, Michael C. G. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) :1310-1315
[10]   NEONATAL SOFT-TISSUE SARCOMAS - THE INFLUENCE OF PATHOLOGY ON TREATMENT AND SURVIVAL [J].
DILLON, PW ;
WHALEN, TV ;
AZIZKHAN, RG ;
HAASE, GM ;
CORAN, AG ;
KING, DR ;
SMITH, M .
JOURNAL OF PEDIATRIC SURGERY, 1995, 30 (07) :1038-1041